In this resource library we share documents, presentations, forms, videos and useful links from Pinnacle and the wider sector.
Use the search box and filters to help find what you're looking for or view all COVID-19 resources
Can't find what you need? Try searching in programmes.
Jo Scott-Jones and Dave Maplesden discuss empagliflozin and ketoacidosis, decision to fund fosfomycin in the community, latent autoimmune diabetes and more.
Jo Scott-Jones and Dave Maplesden discuss treatment refusal, salty navels, warts and gels, coffee and pre-diabetes, and more.
Continuous Blood Glucose Monitoring (CGM) devices are now funded for all people with Type 1 diabetes, and other specific types of diabetes (NOT type 2 diabetes).
Jo Scott-Jones and Dave Maplesden discuss deprescribing, fever in children, pain management and more.
Jo Scott-Jones and Dave Maplesden discuss diverticulitis, new free resources available through Healthpathways, a financial benefits WINZ resource, and more.
A guide for clinical management of type 2 diabetes, including information from a variety of sources. The guide is intended to support nurses at all levels to develop their knowledge and clinical reasoning in diabetes care.
From 30 September 2024, the following insulins will no longer be available in Aotearoa New Zealand: Penmix30, Penmix50 and Mixtard30. NZSSD has issued recommendations for switching to alternative insulins.
A guide for clinical management of type 2 diabetes, including information from a variety of sources. The guide is intended to support nurses at all levels to develop their knowledge and clinical reasoning in diabetes care.
The Aotearoa Diabetes Collective has created a useful guide with templates for letters to support applications for CGM and empagliflozin (for those already prescribed a GLP1ra) for people living with type 2 diabetes.
Please use this one point lesson (linked as a resource to the programme page) and make the fee changes within the Free afterhours U14s advanced form.